BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS)

Clinical trial NCT00910065 · COMPLETED

Trial details

NCT number: NCT00910065
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Coronary Syndrome

Start date: 2011-03-01
Primary completion: 2014-04-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.